Search

everythinglearnresearchcommunity

for

Search:↓

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Exosome-enriched vesicles from placental cells improved skin condition in a patient with chronic graft-versus-host disease.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Hydra can help understand human hair follicle microbiomes and develop new skin disease therapies.

Leprosy is mainly contracted during infancy or childhood.